Smukste et al.
5,17-Bis(3-(2-a m in o-5-gu a n id in op e n t a n oyla m in o)-
p h e n yl)-25,27-b is(m e t h oxyca r b on ylm e t h oxy)ca lix[4]-
a r en e-26,28-d iol (2). A 254 mg (0.16 mg) sample of calix[4]-
arene 9b was dissolved in 5 mL of CHCl3, and 1.5 mL of TFA
was added to the reaction mixture. Deprotection was complete
within 6 h, as determined by TLC analysis. The solvent and
TFA were removed in vacuo, and the crude product was
purified via column chromatography (SiO2, CHCl3, CH3OH)
to give 0.15 g (82%) of calix[4]arene 2 as a yellow oil: 1H NMR
(250 MHz, CDCl3) 8.00-7.80 (m, 2H), 7.63 (s, 2H), 7.50 (d, J
) 7.6 Hz, 2H), 7.36-7.26 (m, 8H), 6.99 (d, J ) 7.4 Hz, 4H),
6.77 (t, J ) 7.4 Hz, 2H), 4.76 (s, 4H), 4.49-4.45 (m, 2H), 4.43
(d, J ) 13.1 Hz, 4H), 3.89 (s, 6H), 3.45 (d, J ) 13.1 Hz, 4H),
3.40-3.11 (m, 4H), 2.04 (s, 6H), 2.00-1.40 (m, 8H); 13C NMR
(63 MHz, CDCl3) δ 170.02, 169.88, 169.12, 157.73, 153.06,
152.47, 152.19, 150.25, 140.42, 139.22, 132.82, 132.31, 131.46,
130.71, 128.85, 128.28, 128.05, 126.74, 124.91, 120.68, 119.83,
116.34, 78.52, 52.58, 51.69, 47.55, 31.52, 28.14, 24.90, 21.60;
13C NMR (63 MHz, DMSO-d6) δ 169.35, 168.92, 154.20, 153.56,
153.13, 152.48, 151.52, 148.40, 141.96, 140.77, 139.48, 133.18,
132.62, 131.21, 130.14, 129.30, 129.14, 128.98, 128.64, 127.20,
126.83, 125.45, 121.38, 120.92, 120.20, 117.39, 117.00, 79.33,
79.17, 72.24, 51.95, 36.40, 35.78, 31.43, 31.49, 30.81, 30.62;
TOF MS m/z calcd for C49H46N3O11+ 852.3132, found 852.3105.
Ca lix[4]a r en e Di[(ter t-bu toxyca r bon yla m in o)ben zo]-
[24]cr ow n -8 Host [2]Rota xa n e (14). A 400 mg (0.589 mmol)
sample of di-Boc-crown ether and 275 mg (0.589 mmol) of
5-(3,5-di-tert-butylbenzylamino)pentanoic acid hexafluorophos-
phate were dissolved in 3 mL of CHCl3. The solution was cooled
to -10 °C (ice/salt bath) for 10 min, and then 146 mg (0.707
mmol) of DCC in 0.5 mL of CHCl3 was added.18 After the
reaction mixture was stirred for 1.5 h, 153 mg (0.442 mmol)
of calix[4]arene 12, dissolved in 0.3 mL of CHCl3, was added.
The reaction was stirred at rt overnight. The solvent was
removed in vacuo, the oily residue was dissolved in CH3CN,
and DCU was removed by filtration. CH3CN was removed by
evaporation, and the crude reaction mixture was triturated
with ethyl ether to remove cyclic tether. The crude product
was purified using rotary chromatography (SiO2, CH2Cl2, CH3-
OH) to give 546 mg (67%) of [2]rotaxane 14. Using this
procedure, [2]rotaxane 14 was obtained in 30-70% yield; the
success of the reaction is very sensitive to the purity of di-
Boc-crown ether: 1H NMR (400 MHz, CDCl3) δ 8.66 (s, 1H),
8.34 (s, 1H), 8.06 (d, J ) 8.0 Hz, 1H), 8.01 (s, 1H), 7.84-7.83
(m, 2H), 7.81 (s, 1H), 7.72 (d, J ) 6.8 Hz, 1H), 7.50 (dt, J )
8.0, 1.6 Hz, 1H), 7.36-6.74 (m, 25H), 6.40 (q, J ) 6.4 Hz, 1H),
4.77-4.76 (m, 4H), 4.55-4.45 (m, 6H), 4.20-4.00 (m, 6H),
4.00-3.93 (m, 4H), 3.89 (s, 6H), 3.60-3.42 (m, 18H), 3.20-
3.05 (m, 4H), 3.90 (m or br s, 2H), 2.63 (m, 2H), 1.85 (m, 2H),
1.49 (s, 18H), 1.31-1.22 (m, 4H), 1.23 (s, 18H); 13C NMR (63
MHz, CDCl3) δ 172.65, 170.25, 169.23, 153.83, 153.16, 152.86,
152.19, 151.17, 148.56, 147.37, 143.00, 141.30, 138.94, 133.15,
132.56, 131.75, 131.30, 129.64, 129.44, 129.11, 128.94, 128.35,
127.97, 127.17, 126.96, 125.81, 124.31, 123.07, 121.61, 121.04,
120.85, 117.68, 113.09, 111.59, 104.92, 80.21, 72.26, 70.34,
69.94, 69.67, 68.41, 68.15, 52.63, 52.20, 48.72, 37.12, 35.71,
35.12, 34.77, 31.55, 31.35, 30.59, 29.62, 28.30, 25.74, 22.24,
+
TOF MS ES+ m/z calcd for C62H71N10O12 1147.5253, found
1147.5204.
5,17-Bis(N-a cetyla r gin yla m in op h en yl)-25,27-bis(m eth -
oxyca r bon ylm eth oxy)ca lix[4]a r en e-26,28-d iol (10). A 120
mg (0.071 mg) sample of of calix[4]arene 9a was dissolved in
5 mL of CH2Cl2, and 3.0 mL of TFA was added to the reaction
mixture. Complete deprotection required 24 h. The solvent and
TFA were removed in vacuo, and the crude product was
purified via column chromatography (SiO2, CHCl3, CH3OH)
to give 0.030 g (41%) of calix[4]arene 10 as a yellow oil: 1H
NMR (250 MHz, CDCl3) δ 7.15-7.33 (8H, m), 6.93-7.00 (6H,
m), 6.88 (2H, s), 6.78 (2H, t, J ) 7.5 Hz), 6.65 (2H, d, J ) 8.3
Hz), 4.78 (4H, s), 4.50 (4H, d, J ) 13.1 Hz), 4.20-4.40 (2H,
m), 3.90 (6H, s), 3.47 (4H, d, J ) 13.1 Hz), 1.10-1.90 (6H, m),
0.86-0.89 (4H, m); 13C NMR (63 MHz, CDCl3) δ 171.5, 168.3,
167.2, 153.8, 153.4, 143.2, 139.3, 134.3, 133.2, 130.5, 130.3,
130.0, 128.3, 126.7, 124.0, 119.3, 73.3, 55.1, 52.9, 41.8, 32.1,
29.8, 25.5; TOF MS ES+ m/z calcd for C58H67N10O10+ 1063.5041,
found 1063.5146.
5-[3-(3-ter t-Bu t oxyca r b on yla m in op r op ion yla m in o)-
p h en yl]-17-(3-a m in op h en yl)-25,27-bis(m eth oxyca r bon yl-
m eth oxy)ca lix[4]a r en e-26,28-d iol (11). To a solution of 436
mg (2.30 mmol) of Boc-â-alanine in 20 mL of CHCl3 was added
374 mg (2.30 mmol) of CDI. The reaction was stirred at rt for
1 h, and then 600 mg (0.768 mmol) of calix[4]arene 8 and 52
mg (0.77 mmol) of imidazole were added to the solution. The
reaction mixture was stirred at rt for 30 min and then refluxed
for 4 h. The solvents were removed in vacuo. Flash chroma-
tography (SiO2, CHCl3, C2H5OH) afforded 703 mg (96%) of
+
20.95, 14.14, 13.63; TOF MS m/z calcd for C103H127N6O24
1831.8902, found 1831.8905.
Ca lix[4]a r en e Di(a m in oben zo)[24]cr ow n -8 Host [2]-
Rota xa n e (15). A 480 mg (0.243 mmol) sample of calix[4]-
arene rotaxane 14 was dissolved in 10 mL of CH2Cl2, and 3
mL of TFA was added. After the reaction was stirred at rt for
3 h, volatile materials were removed under high vacuum. To
remove traces of TFA, the crude product was dissolved in 10
mL of a CH2Cl2/CH3OH (2/1) solution, which was subsequently
removed under high vacuum. This procedure was repeated
several times. Crude [2]rotaxane 15 was dissolved in CH2Cl2/
CH3OH (9/1) and extracted with 0.1 N NHCO3. The organic
phase was collected and dried over Na2SO4, and the solvent
was removed in vacuo to give 378 mg (89%) of the rotaxane 9,
which was used without further purification: 1H NMR (400
MHz, CDCl3) δ 8.03-7.50 (m, 6H), 7.40-6.84 (m, 17H), 6.70-
6.60 (m, 6H), 6.56-6.52 (m, 2H), 6.30-6.20 (m, 2H), 4.71 (s,
4H), 4.53-4.39 (m, 6H), 4.12-3.20 (m, 6H (-OCH3), 24H
(DB24C8), 4H (ArCH2Ar), 4H (-NH2)), 3.09-2.80 (m, 6H),
2.75-2.70 (m, 4H), 1.75-1.79 (m, 2H), 1.27 (s, 18H), 1.27-
1.14 (4H); 13C NMR (63 MHz, CDCl3) δ 171.12, 169.53, 169.44,
152.69, 152.57, 151.81, 151.06, 147.82, 141.76, 140.87, 139.74,
132.95, 132.79, 132.41, 131.93, 131.58, 130.29, 129.06, 128.52,
128.14, 126.87, 125.66, 124.54, 123.00, 121.00, 119.27, 117.42,
114.00, 109.94, 103.60, 77.17, 72.16, 70.10, 69.03, 68.65, 68.02,
60.25, 52.27, 48.60, 45.53, 36.10, 34.76, 31.33, 25.77, 22.11,
20.93; TOF MS m/z calcd for C93H111N6O20+ 1631.7853, found
1631.7805.
1
calix[4]arene 11 as a yellow solid: mp 145-150 °C; H NMR
(250 MHz, CDCl3) δ 7.70-7.67 (m, 2H), 7.54-7.26 (m, 8H),
7.05 (d, J ) 7.4 Hz, 1H), 6.97-6.91 (m, 4H), 6.90-6.76 (m,
2H), 6.65 (t, J ) 7.5 Hz, 1H), 4.75 (s, 4H), 4.53-4.44 (m, 4H),
3.88 (s, 6H), 3.53-3.38 (m, 6H), 2.63 (t, J ) 5.5 Hz), 1.44 (s,
9H); 13C NMR (63 MHz, CDCl3) δ 169.78, 169.11, 156.22,
153.66, 152.77, 152.18, 148.47, 142.69, 141.89, 138.22, 132.93,
132.82, 132.68, 132.52, 132.40, 132.18, 131.68, 130.67, 130.08,
129.33, 129.08, 128.81, 128.38, 128.22, 128.01, 127.11, 125.60,
125.48, 122.50, 121.04, 120.83, 119.11, 117.93, 117.77, 79.37,
77.17, 72.14, 52.09, 37.35, 36.46, 31.43, 31.27, 28.27; TOF MS
+
m/z calcd for C54H54N3O13 952.3657, found 952.3703.
5-[3-(3-Am in op r op ion yla m in o)p h en yl]-17-(3-a m in o-
p h e n yl)-25,27-b is(m e t h oxyca r b on ylm e t h oxy)ca lix[4]-
a r en e-26,28-d iol (12). A 667 mg (0.700 mmol) sample of calix-
[4]arene 11 was dissolved in 10 mL of CHCl3, and 3 mL of
TFA was added. After the reaction mixture was stirred at rt
for 1 h, the solvent and TFA were removed in vacuo, and the
product was purified by column chromatography (SiO2, CHCl3,
CH3OH) to give 504 mg (84%) of calix[4]arene 12: mp 284 °C
dec; 1H NMR (400 MHz, CDCl3) δ 9.99 (br s, 1H), 7.72 (s, 1H),
7.47-7.46 (m, 2H), 7.33-7.22 (m, 6H), 7.05 (d, J ) 4.5 Hz,
1H), 6.98-6.91 (m, 4H), 6.77-6.73 (m, 2H), 6.66 (t, J ) 4.5
Hz, 1H), 4.75 (s, 4H), 4.56-4.44 (m, 4H), 3.88 (s, 6H), 3.51-
3.36 (m, 4H), 3.09 (t, J ) 3.3 Hz, 2H), 2.49 (t, J ) 3.3 Hz, 2H);
Ca lix[4]a r en e Di[(N-a cetyla r gin yla m in o)ben zo][24]-
cr ow n -8 Host-[2]Rota xa n e (1). A 370 mg (0.227 mmol)
sample of amino[2]rotaxane 15, 148 mg (0.681 mmol) of Ac-
Arg-OH‚HCl, and 302 mg (0.681 mmol) of BOP were dissolved
in 3 mL of DMF. A 316 µL sample of DIEA was added to the
2570 J . Org. Chem., Vol. 68, No. 7, 2003